Production rates of dihydrotestosterone in healthy men and women and in men with male pattern baldness: Determination by stable isotope/dilution and mass spectrometry

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 12, 2001, Pages 5762-5764

  Vierhapper, H ^a   Nowotny, P ^a   Maier, H ^a   Waldhausl W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ISOTOPE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; ANDROGEN SYNTHESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DILUTION; FEMALE; FOLLICULAR PHASE; HUMAN; IN VIVO STUDY; MALE; MALE TYPE ALOPECIA; MASS SPECTROMETRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REFERENCE VALUE;

EID: 0035217642     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.12.8078     Document Type: Article

References (24)

1. Determination of testosterone production rates in men and women using stable isotope/dilution and mass spectrometry
2. 13C-labelled testosterone in man
3. 13C-labelled testosterone in humans
4. Male pattern baldness and coronary heart disease. The physicians' health study
5. Novel partial synthetic approaches to replace carbons 2,3,4 of steroids. A methodology to label testosterone and progesterone with C-13 in the steroid a ring. Part 1
6. 13C in the steroid A ring. Part 2
7. Calculation of turnover rates in stable-isotope studies
8. Normal serum concentrations of sex hormone binding globulin in patients with hyperthyroidism due to subacute thyroiditis
9. Steroid 5α-reductase 2 deficiency
10. An explanation for the target organ responsiveness to testosterone in the testicular feminization syndrome
11. Relationship between plasma testosterone and dihydrotestosterone concentrations and male facial hair growth
12. Effects of finasteride (MK-906), a 5α-reductase inihitor, on circulating androgens in male volunteers
13. Finasteride
14. Finasteride in the treatment of men with androgenetic alopecia
15. The effect of finasteride, a 5αreductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness
16. The source of plasma dihydrotestosterone in man
17. The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-α-androstanediols
18. Blood production rate of dihydrotestosterone in the syndrome of male pseudohermaphroditism with testicular feminization
19. Circulating dihydrotestosterone may not reflect peripheral formation
20. Unchanged testosterone production rates in growth hormone-treated healthy men
21. Production rates of testosterone in patients with Cushing's syndrome
22. Sex-specific differences in cortisol production rates in humans
23. Treatment with growth hormone suppresses cortisol production in man
24. The direct pituitary effect of testosterone to inhibit gonadotropin concentrations in men is partially mediated by aromatization to estradiol